The associations of the Panel 2 markers MAL2, EMP2, CCNE2 and HJURP with short OS may point to different biological characteristics of the enriched cells and warrant further studies in aggressive breast cancer subtypes. This evidence concerns the gene MAL2 and breast carcinoma.